lower extremity artery disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients underwent abdominal contrast-enhanced CT in Hyogo Prefectural Awaji Medical Center, from January 2014 to March 2021.
Exclusion criteria
Exclusion criteria: Patients with symptomatic LEAD Patients with history of ASCVD Patients who underwent abdominal contrast-enhanced CT for traumatic survey Patients who underwent revascularization for iliac arterie Patients whose life expectancy are estimated to less than a year Patients whose clinical follow-up had ceased after abdominal contrast-enhanced CT date
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiovascular Events (MACE): a composite of cardiovascular death, non-fatal MI, non-fatal stroke, and any revascularization | — |
Secondary
| Measure | Time frame |
|---|---|
| CardioVascular Event requiring TransFemoral approach (TF-CVE): a composite of cardiogenic shock, acute coronary syndrome, any stroke, and thoracoabdominal aortic aneurysm treated with stent graft | — |
Countries
Japan
Contacts
Hyogo Prefectural Awaji Medical Center Department of Cardiology